BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Monica M. Betancourt-Garcia, Armando Arguelles, Jorge Montes, Ambrosio Hernandez, Manish Singh, R. Armour Forse. Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic ChildrenObesity Surgery 2017; 27(1): 236 doi: 10.1007/s11695-016-2440-5
2
Amjad M. Ahmed, Mohamed E. Ebid, Amr M. Ajlan, Mouaz H. Al-Mallah. Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver diseaseAbdominal Radiology 2017; 42(10): 2454 doi: 10.1007/s00261-017-1166-8
3
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Angela M Madden. Lifestyle modifications for non-alcohol related fatty liver disease: a network meta-analysisCochrane Database of Systematic Reviews 2018;  doi: 10.1002/14651858.CD013156
4
Roxana Gutiérrez-Vidal, Blanca Delgado-Coello, Kevin Manuel Méndez-Acevedo, Sandra Calixto-Tlacomulco, Salvador Damián-Zamacona, Jaime Mas-Oliva. Therapeutic Intranasal Vaccine HB-ATV-8 Prevents Atherogenesis and Non-alcoholic Fatty Liver Disease in a Pig Model of AtherosclerosisArchives of Medical Research 2018; 49(7): 456 doi: 10.1016/j.arcmed.2019.01.007
5
Daria L Varganova, Chavdar S Pavlov, Giovanni Casazza, Dimitrinka Nikolova, Christian Gluud. Essential phospholipids for people with non-alcoholic fatty liver diseaseCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD013301
6
Uchenna Agbim, Rotonya M. Carr, Octavia Pickett-Blakely, Sam Dagogo-Jack. Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized ObesityCurrent Obesity Reports 2019; 8(3): 243 doi: 10.1007/s13679-019-00349-x
7
Zobair M. Younossi, Linda Henry, Haley Bush, Alita Mishra. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisClinics in Liver Disease 2018; 22(1): 1 doi: 10.1016/j.cld.2017.08.001
8
Eduardo Velasco-Mondragon, Angela Jimenez, Anna G. Palladino-Davis, Dawn Davis, Jose A. Escamilla-Cejudo. Hispanic health in the USA: a scoping review of the literaturePublic Health Reviews 2016; 37(1) doi: 10.1186/s40985-016-0043-2
9
Yutao Zhan, Ping Xie, Dongnian Li, Li Li, Jing Chen, Wei An, Lingqiang Zhang, Chuan Zhang. Deficiency of CKIP-1 aggravates high-fat diet-induced fatty liver in miceExperimental Cell Research 2017; 355(1): 40 doi: 10.1016/j.yexcr.2017.03.033
10
A. Rivera-Andrade, M.F. Kroker-Lobos, M. Lazo, N.D. Freedman, J.W. Smith, O. Torres, K.A. McGlynn, J.D. Groopman, E. Guallar, M. Ramirez-Zea. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based studyNutrition, Metabolism and Cardiovascular Diseases 2019; 29(2): 191 doi: 10.1016/j.numecd.2018.10.008
11
Pegah Golabi, Mehmet Sayiner, Yousef Fazel, Aaron Koenig, Linda Henry, Zobair M Younossi. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosisExpert Review of Gastroenterology & Hepatology 2016; 10(1): 63 doi: 10.1586/17474124.2016.1099433
12
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.85780
13
Sammy Saab, Vignan Manne, Jose Nieto, Jeffrey B. Schwimmer, Naga P. Chalasani. Nonalcoholic Fatty Liver Disease in LatinosClinical Gastroenterology and Hepatology 2016; 14(1): 5 doi: 10.1016/j.cgh.2015.05.001
14
Rosa Lombardi, Simona Onali, Douglas Thorburn, Brian R Davidson, Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)Cochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD011640.pub2
15
Rosemay A. Remigio-Baker, Matthew A. Allison, Nketi I. Forbang, Rohit Loomba, Cheryl A.M. Anderson, Matthew Budoff, Jeffrey B. Schwimmer, Roger S. Blumenthal, Pamela Ouyang, Michael H. Criqui. Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of AtherosclerosisAtherosclerosis 2017; 258: 89 doi: 10.1016/j.atherosclerosis.2016.11.021
16
J.A. Weintraub, G. Lopez Mitnik, B.A. Dye. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United StatesJournal of Dental Research 2019; 98(11): 1219 doi: 10.1177/0022034519866442
17
Jennifer K. Frediani, Eric A. Naioti, Miriam B. Vos, Janet Figueroa, Carmen J. Marsit, Jean A. Welsh. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005–2014Environmental Health 2018; 17(1) doi: 10.1186/s12940-017-0350-1
18
Mehmet Sayiner, Aaron Koenig, Linda Henry, Zobair M. Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the WorldClinics in Liver Disease 2016; 20(2): 205 doi: 10.1016/j.cld.2015.10.001
19
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for managementWorld Journal of Hepatology 2017; 9(11): 533-543 doi: 10.4254/wjh.v9.i11.533
20
Hadi Emamat, Hossein Farhadnejad, Hossein Poustchi, Azita Hekmatdoost. Galactose intake is related to nonalcoholic fatty liver diseaseNutrition & Food Science 2019; 49(3): 359 doi: 10.1108/NFS-06-2018-0174
21
Rotonya M. Carr, Amanke Oranu, Vandana Khungar. Nonalcoholic Fatty Liver DiseaseGastroenterology Clinics of North America 2016; 45(4): 639 doi: 10.1016/j.gtc.2016.07.003
22
Huei-Wen Lim, David E. Bernstein. Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including GeneticsClinics in Liver Disease 2018; 22(1): 39 doi: 10.1016/j.cld.2017.08.008
23
Tong-shuo Zhang, Hua-lei Qin, Tong Wang, Hai-tao Li, Hai Li, Shi-hai Xia, Xiao-hui Xiang. Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic reviewSpringerPlus 2015; 4(1) doi: 10.1186/s40064-015-1542-1
24
Mariana Lazo, Usama Bilal, Rafael Perez-Escamilla. Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic OriginCurrent Diabetes Reports 2015; 15(12) doi: 10.1007/s11892-015-0674-6
25
Zobair Younossi, Quentin M. Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Global burden of NAFLD and NASH: trends, predictions, risk factors and preventionNature Reviews Gastroenterology & Hepatology 2018; 15(1): 11 doi: 10.1038/nrgastro.2017.109
26
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Angela M Madden. Nutritional supplementation for non-alcohol-related fatty liver disease: a network meta-analysisCochrane Database of Systematic Reviews 2018;  doi: 10.1002/14651858.CD013157
27
Kurinchi Selvan Gurusamy, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Cochrane Database of Systematic Reviews2015;  doi: 10.1002/14651858.CD011640
28
Yutao Zhan, Fei Zhao, Ping Xie, Leping Zhong, Dongnian Li, Qujing Gai, Li Li, Hongshan Wei, Lingqiang Zhang, Wei An. Mechanism of the effect of glycosyltransferase GLT8D2 on fatty liverLipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0040-3
29
Yu-Tao Zhan, Hai-Ying Su, Wei An. Glycosyltransferases and non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2016; 22(8): 2483-2493 doi: 10.3748/wjg.v22.i8.2483